289 related articles for article (PubMed ID: 34866323)
1. Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma.
Matsushima K; Sonoda D; Mitsui A; Tamagawa S; Hayashi S; Naito M; Matsui Y; Shiomi K; Satoh Y
Thorac Cancer; 2022 Jan; 13(1):48-53. PubMed ID: 34866323
[TBL] [Abstract][Full Text] [Related]
2. Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis.
Chang C; Sun X; Zhao W; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Xie W; Shen J
Radiol Med; 2020 Mar; 125(3):257-264. PubMed ID: 31823295
[TBL] [Abstract][Full Text] [Related]
3. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
[TBL] [Abstract][Full Text] [Related]
4. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
[No Abstract] [Full Text] [Related]
5. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Kaseda K; Asakura K; Kazama A; Ozawa Y
World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
[TBL] [Abstract][Full Text] [Related]
7. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
[TBL] [Abstract][Full Text] [Related]
8. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Characteristics of Lung Adenocarcinoma with Unexpected Lymph Node Metastasis.
Haruki T; Wakahara M; Matsuoka Y; Miwa K; Araki K; Taniguchi Y; Nakamura H
Ann Thorac Cardiovasc Surg; 2017 Aug; 23(4):181-187. PubMed ID: 28539542
[TBL] [Abstract][Full Text] [Related]
11. Video-assisted thoracic surgery systematic mediastinal nodal dissection and stage migration: impact on clinical pathway.
Amer K; Khan AZ; Singh N; Addis B; Jogai S; Harden S; Peebles C; Brown I
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1474-81. PubMed ID: 21497109
[TBL] [Abstract][Full Text] [Related]
12. Impact of
Al-Ibraheem A; Hirmas N; Fanti S; Paez D; Abuhijla F; Al-Rimawi D; Al-Rasheed U; Abdeljalil R; Hawari F; Alrabi K; Mansour A
BMC Med Imaging; 2021 Mar; 21(1):49. PubMed ID: 33731050
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Segmental Lymph Node Metastasis and Clinical Features in cT1N0M0 Lung Adenocarcinoma.
Sun G; Sun Y; Zou Z; Xu S
Biomed Res Int; 2020; 2020():2842604. PubMed ID: 32149096
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.
Moon Y; Kim KS; Lee KY; Sung SW; Kim YK; Park JK
Ann Thorac Surg; 2016 May; 101(5):1928-35. PubMed ID: 26952299
[TBL] [Abstract][Full Text] [Related]
16. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS
Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636
[TBL] [Abstract][Full Text] [Related]
17. Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET.
Eriguchi D; Shimada Y; Imai K; Furumoto H; Okano T; Masuno R; Matsubayashi J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2018 Nov; 125():14-21. PubMed ID: 30429012
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [
Tsutani Y; Nakayama H; Ito H; Handa Y; Mimae T; Miyata Y; Okada M
Clin Lung Cancer; 2021 May; 22(3):e431-e437. PubMed ID: 32665166
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]